• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用诱导多能干细胞衍生的心肌细胞对儿茶酚胺能多形性室性心动过速进行建模。

Modeling Catecholaminergic Polymorphic Ventricular Tachycardia using Induced Pluripotent Stem Cell-derived Cardiomyocytes.

作者信息

Novak Atara, Lorber Avraham, Itskovitz-Eldor Joseph, Binah Ofer

机构信息

The Sohnis Family Stem Cells Center, Technion - Israel Institute of Technology, Haifa, Israel; ; The Rappaport Family Institute for Research in the Medical Sciences, Technion - Israel Institute of Technology, Haifa, Israel; ; Ruth & Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel;

出版信息

Rambam Maimonides Med J. 2012 Jul 31;3(3):e0015. doi: 10.5041/RMMJ.10086. Print 2012 Jul.

DOI:10.5041/RMMJ.10086
PMID:23908839
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3678817/
Abstract

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmogenic cardiac disorder characterized by life-threatening arrhythmias induced by physical or emotional stress, in the absence structural heart abnormalities. The arrhythmias may cause syncope or degenerate into cardiac arrest and sudden death which usually occurs during childhood. Recent studies have shown that CPVT is caused by mutations in the cardiac ryanodine receptor type 2 (RyR2) or calsequestrin 2 (CASQ2) genes. Both proteins are key contributors to the intracellular Ca(2+) handling process and play a pivotal role in Ca(2+) release from the sarcoplasmic reticulum to the cytosol during systole. Although the molecular pathogenesis of CPVT is not entirely clear, it was suggested that the CPVT mutations promote excessive sarcoplasmic reticulum Ca(2+) leak, which initiates delayed afterdepolarizations (DADs) and triggered arrhythmias in cardiac myocytes. The recent breakthrough discovery of induced pluripotent stem cells (iPSC) generated from somatic cells (e.g. fibroblasts, keratinocytes) now enables researches to investigate mutated cardiomyocytes generated from the patient's iPSC. To this end, in the present article we review recent studies on CPVT iPSC-derived cardiomyocytes, thus demonstrating in the mutated cells catecholamine-induced DADs and triggered arrhythmias.

摘要

儿茶酚胺能多形性室性心动过速(CPVT)是一种遗传性致心律失常性心脏病,其特征是在无结构性心脏异常的情况下,由身体或情绪应激诱发危及生命的心律失常。这些心律失常可能导致晕厥或恶化为心脏骤停和猝死,通常发生在儿童期。最近的研究表明,CPVT是由心脏2型兰尼碱受体(RyR2)或肌集钙蛋白2(CASQ2)基因突变引起的。这两种蛋白质都是细胞内钙(Ca2+)处理过程的关键因素,并且在收缩期从肌浆网向细胞质的钙(Ca2+)释放中起关键作用。虽然CPVT的分子发病机制尚不完全清楚,但有人认为CPVT突变会促进肌浆网钙(Ca2+)过度泄漏,从而引发延迟后去极化(DADs)并触发心肌细胞心律失常。最近从体细胞(如成纤维细胞、角质形成细胞)产生诱导多能干细胞(iPSC)的突破性发现,现在使研究人员能够研究由患者iPSC产生的突变心肌细胞。为此,在本文中我们综述了关于CPVT iPSC衍生心肌细胞的最新研究,从而在突变细胞中证明了儿茶酚胺诱导的DADs和触发的心律失常。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be11/3678817/d6c1eadfaaf5/rmmj-3-3-e0015_Figure6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be11/3678817/4a64a563e07e/rmmj-3-3-e0015_Figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be11/3678817/24836819cef0/rmmj-3-3-e0015_Figure2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be11/3678817/bfd3a8fd4918/rmmj-3-3-e0015_Figure3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be11/3678817/d3ab6082989d/rmmj-3-3-e0015_Figure4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be11/3678817/4b49c66369c3/rmmj-3-3-e0015_Figure5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be11/3678817/d6c1eadfaaf5/rmmj-3-3-e0015_Figure6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be11/3678817/4a64a563e07e/rmmj-3-3-e0015_Figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be11/3678817/24836819cef0/rmmj-3-3-e0015_Figure2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be11/3678817/bfd3a8fd4918/rmmj-3-3-e0015_Figure3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be11/3678817/d3ab6082989d/rmmj-3-3-e0015_Figure4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be11/3678817/4b49c66369c3/rmmj-3-3-e0015_Figure5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be11/3678817/d6c1eadfaaf5/rmmj-3-3-e0015_Figure6.jpg

相似文献

1
Modeling Catecholaminergic Polymorphic Ventricular Tachycardia using Induced Pluripotent Stem Cell-derived Cardiomyocytes.使用诱导多能干细胞衍生的心肌细胞对儿茶酚胺能多形性室性心动过速进行建模。
Rambam Maimonides Med J. 2012 Jul 31;3(3):e0015. doi: 10.5041/RMMJ.10086. Print 2012 Jul.
2
Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations.携带兰尼碱或肌集钙蛋白突变的CPVT1和CPVT2患者来源的诱导多能干细胞衍生心肌细胞中的功能异常。
J Cell Mol Med. 2015 Aug;19(8):2006-18. doi: 10.1111/jcmm.12581. Epub 2015 Jul 8.
3
Patient Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Development and Screening In Catecholaminergic Polymorphic Ventricular Tachycardia.用于儿茶酚胺能多形性室性心动过速药物开发和筛选的患者特异性诱导多能干细胞衍生心肌细胞
J Atr Fibrillation. 2016 Aug 31;9(2):1423. doi: 10.4022/jafib.1423. eCollection 2016 Aug-Sep.
4
Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation.来自 CPVTD307H 患者的心肌细胞对β-肾上腺素刺激反应性心律失常。
J Cell Mol Med. 2012 Mar;16(3):468-82. doi: 10.1111/j.1582-4934.2011.01476.x.
5
Novel Calmodulin Variant p.E46K Associated With Severe Catecholaminergic Polymorphic Ventricular Tachycardia Produces Robust Arrhythmogenicity in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.与严重儿茶酚胺能多形性室性心动过速相关的新型钙调蛋白变体p.E46K在人诱导多能干细胞衍生的心肌细胞中产生强大的致心律失常性。
Circ Arrhythm Electrophysiol. 2023 Mar;16(3):e011387. doi: 10.1161/CIRCEP.122.011387. Epub 2023 Mar 3.
6
Efficacy of RyR2 inhibitor EL20 in induced pluripotent stem cell-derived cardiomyocytes from a patient with catecholaminergic polymorphic ventricular tachycardia.兰尼碱受体2(RyR2)抑制剂EL20对儿茶酚胺能多形性室性心动过速患者诱导多能干细胞衍生心肌细胞的疗效
J Cell Mol Med. 2021 Jun 10;25(13):6115-24. doi: 10.1111/jcmm.16521.
7
Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells.应用患者特异性人诱导多能干细胞对儿茶酚胺多形性室性心动过速进行建模。
J Am Coll Cardiol. 2012 Sep 11;60(11):990-1000. doi: 10.1016/j.jacc.2012.02.066. Epub 2012 Jun 27.
8
Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights.儿茶酚胺能多形性室性心动过速:近期机制新见解
Cardiovasc Res. 2005 Aug 15;67(3):379-87. doi: 10.1016/j.cardiores.2005.04.027.
9
Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations.儿茶酚胺多形性室性心动过速的细胞模型显示早期和延迟后除极。
PLoS One. 2012;7(9):e44660. doi: 10.1371/journal.pone.0044660. Epub 2012 Sep 4.
10
A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.儿茶酚胺能多形性室性心动过速的人多能干细胞模型概括了患者特异性药物反应。
Dis Model Mech. 2016 Sep 1;9(9):927-39. doi: 10.1242/dmm.026823. Epub 2016 Aug 4.

引用本文的文献

1
Human Induced Pluripotent Stem Cells Derived from a Cardiac Somatic Source: Insights for an In-Vitro Cardiomyocyte Platform.人心源性诱导多能干细胞:体外心肌细胞平台的新视角。
Int J Mol Sci. 2020 Jan 13;21(2):507. doi: 10.3390/ijms21020507.
2
Mutation-specific differences in arrhythmias and drug responses in CPVT patients: simultaneous patch clamp and video imaging of iPSC derived cardiomyocytes.CPVT 患者心律失常和药物反应的突变特异性差异:iPSC 衍生心肌细胞的膜片钳和视频成像的同步检测。
Mol Biol Rep. 2020 Feb;47(2):1067-1077. doi: 10.1007/s11033-019-05201-y. Epub 2019 Nov 30.
3
Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening.

本文引用的文献

1
Calsequestrin 2 and arrhythmias.钙结合蛋白 2 与心律失常。
Am J Physiol Heart Circ Physiol. 2012 Mar 15;302(6):H1250-60. doi: 10.1152/ajpheart.00779.2011. Epub 2011 Dec 23.
2
In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells.利用人类诱导多能干细胞对兰尼碱受体2功能障碍进行体外建模。
Cell Physiol Biochem. 2011;28(4):579-92. doi: 10.1159/000335753. Epub 2011 Dec 14.
3
Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia.
用于疾病建模和药物筛选的人诱导多能干细胞衍生心肌细胞及组织工程策略。
Biotechnol Adv. 2017 Jan-Feb;35(1):77-94. doi: 10.1016/j.biotechadv.2016.12.002. Epub 2016 Dec 20.
4
Patient Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Development and Screening In Catecholaminergic Polymorphic Ventricular Tachycardia.用于儿茶酚胺能多形性室性心动过速药物开发和筛选的患者特异性诱导多能干细胞衍生心肌细胞
J Atr Fibrillation. 2016 Aug 31;9(2):1423. doi: 10.4022/jafib.1423. eCollection 2016 Aug-Sep.
5
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease Modeling.人诱导多能干细胞衍生的心肌细胞为遗传性心血管疾病建模带来新机遇。
Cardiol Res Pract. 2016;2016:3582380. doi: 10.1155/2016/3582380. Epub 2016 Mar 27.
6
Calcium signaling in human stem cell-derived cardiomyocytes: Evidence from normal subjects and CPVT afflicted patients.人干细胞衍生心肌细胞中的钙信号传导:来自正常受试者和儿茶酚胺能多形性室性心动过速患者的证据。
Cell Calcium. 2016 Mar;59(2-3):98-107. doi: 10.1016/j.ceca.2015.12.002. Epub 2015 Dec 15.
7
Excitation-contraction coupling of human induced pluripotent stem cell-derived cardiomyocytes.人诱导多能干细胞衍生心肌细胞的兴奋-收缩偶联
Front Cell Dev Biol. 2015 Sep 29;3:59. doi: 10.3389/fcell.2015.00059. eCollection 2015.
8
Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations.携带兰尼碱或肌集钙蛋白突变的CPVT1和CPVT2患者来源的诱导多能干细胞衍生心肌细胞中的功能异常。
J Cell Mol Med. 2015 Aug;19(8):2006-18. doi: 10.1111/jcmm.12581. Epub 2015 Jul 8.
9
Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.培养皿中的心肌病:利用人类诱导多能干细胞模拟遗传性心肌病
J Card Fail. 2015 Sep;21(9):761-70. doi: 10.1016/j.cardfail.2015.04.010. Epub 2015 Apr 28.
丹曲林钠挽救儿茶酚胺多形性室性心动过速患者特异性干细胞模型中的致心律失常 RYR2 缺陷。
EMBO Mol Med. 2012 Mar;4(3):180-91. doi: 10.1002/emmm.201100194. Epub 2012 Jan 25.
4
Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation.来自 CPVTD307H 患者的心肌细胞对β-肾上腺素刺激反应性心律失常。
J Cell Mol Med. 2012 Mar;16(3):468-82. doi: 10.1111/j.1582-4934.2011.01476.x.
5
Mechanism underlying catecholaminergic polymorphic ventricular tachycardia and approaches to therapy.儿茶酚胺能多形性室性心动过速的潜在机制及治疗方法。
J Electrocardiol. 2011 Nov-Dec;44(6):650-5. doi: 10.1016/j.jelectrocard.2011.07.025. Epub 2011 Aug 27.
6
Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis.肌浆网 Ca2+ 处理功能遗传性缺陷与心律失常发生。
Circ Res. 2011 Apr 1;108(7):871-83. doi: 10.1161/CIRCRESAHA.110.226845.
7
Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation.携长 QT 综合征 2 型突变的人诱导多能干细胞衍生的心肌细胞中的药物评估。
Eur Heart J. 2011 Apr;32(8):952-62. doi: 10.1093/eurheartj/ehr073. Epub 2011 Mar 2.
8
Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome.利用诱导多能干细胞研究 Timothy 综合征的心脏表型。
Nature. 2011 Mar 10;471(7337):230-4. doi: 10.1038/nature09855. Epub 2011 Feb 9.
9
Modelling the long QT syndrome with induced pluripotent stem cells.利用诱导多能干细胞构建长 QT 综合征模型。
Nature. 2011 Mar 10;471(7337):225-9. doi: 10.1038/nature09747. Epub 2011 Jan 16.
10
Enhanced reprogramming and cardiac differentiation of human keratinocytes derived from plucked hair follicles, using a single excisable lentivirus.使用单一可切除慢病毒增强从拔取的毛囊中获得的人角质形成细胞的重编程和心脏分化。
Cell Reprogram. 2010 Dec;12(6):665-78. doi: 10.1089/cell.2010.0027. Epub 2010 Oct 21.